Joel Harris is a co-founder and the CEO of Genvax Technologies. Genvax Technologies was founded in 2021, and is developing herd-specific, prescription RNA + nanoparticle vaccines for the livestock industry, with an initial focus on swine. Harris also serves as Executive Director for the Ag Startup Engine, a pre-seed stage investment group focused on Midwest agricultural innovation. He previously started another RNA livestock vaccine company alongside his father. Their company, Harrisvaccines, was sold to Merck Animal Health in 2015. After selling Harrisvaccines and prior to starting Genvax Technologies, Harris spent time on the investment side of the startup world with groups like Ag Startup Engine and Vitalize Venture Group. Harris has a B.A. in Economics from the University of Iowa and a Professional Certificate in Narrative Communications from Northwestern University.